[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100602038":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":18,"responsibleParty":91,"collaborators":93,"id":98,"slug":10,"hasResults":99,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":10,"eligibilityCriteria":103,"healthyVolunteers":99,"sex":104,"minAge":105,"maxAge":10,"enrollmentInfo":106,"targetDuration":10,"studyType":109,"phases":10,"briefSummary":110,"conditions":111,"keywords":113,"overallStatus":43,"whyStopped":10,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":127},{"fullName":5,"class":6},"Viz.ai, Inc.","INDUSTRY",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Experimental Cohort",null,"Prospective patients presenting to sites after implementation of the digital health tool.",{"label":13,"type":10,"description":14,"interventionNames":10},"Control Cohort","Retrospective patients who presented to the same study sites under the standard of care clinical workflow before implementation of the digital health tool",{"label":16,"type":10,"description":17,"interventionNames":10},"Exploratory Cohort","Patients who had no prior respiratory specialist follow up before implementation of the digital health tool and are re-assessed for follow up after implementation of the digital health tool.",[19,41,60,77],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Advocate Lutheran General Hospital","NOT_YET_RECRUITING","Park Ridge","Illinois","60068","United States",{"type":27,"coordinates":28},"Point",[29,30],-87.84062,42.01114,{"lat":30,"lon":29},[33,38],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Manager Clinical Trials Research, Multispecialty","CONTACT","920-360-9415","alexander.albers@aah.org",{"name":39,"role":40,"phone":10,"phoneExt":10,"email":10},"Bhaven Shah, MD","SUB_INVESTIGATOR",{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":25,"cosmosGeoPoint":47,"geoPoint":51,"contacts":52},"Cooper University Health Care","RECRUITING","Cherry Hill","New Jersey","08002",{"type":27,"coordinates":48},[49,50],-75.03073,39.93484,{"lat":50,"lon":49},[53,57],{"name":54,"role":35,"phone":55,"phoneExt":10,"email":56},"Study Coordinator","856-968-7366","Vincent-Asia@CooperHealth.edu",{"name":58,"role":59,"phone":10,"phoneExt":10,"email":10},"Ramya Lotano, MD","PRINCIPAL_INVESTIGATOR",{"facility":61,"status":43,"city":62,"state":63,"zip":64,"country":25,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Thomas Jefferson University","Philadelphia","Pennsylvania","19107",{"type":27,"coordinates":66},[67,68],-75.16362,39.95238,{"lat":68,"lon":67},[71,75],{"name":72,"role":35,"phone":73,"phoneExt":10,"email":74},"Research Coordinator","215-955-9181","pritika.manna@jefferson.edu",{"name":76,"role":59,"phone":10,"phoneExt":10,"email":10},"Ross Summer, MD",{"facility":78,"status":21,"city":79,"state":80,"zip":81,"country":25,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Aurora St. Luke's Medical Center","Milwaukee","Wisconsin","53215",{"type":27,"coordinates":83},[84,85],-87.90647,43.0389,{"lat":85,"lon":84},[88,89],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},{"name":90,"role":59,"phone":10,"phoneExt":10,"email":10},"Theodore Gronski, MD",{"type":92,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[94,96],{"name":95,"class":6},"Sanofi",{"name":97,"class":6},"Regeneron Pharmaceuticals","100602038",false,"NCT07118306","COPD Exacerbation Follow Up","A Multicenter Study of the Impact of a COPD Identification and Referral System on Patient Follow Up and Outcomes After an Acute COPD Exacerbation Resulting in an Emergency Department Visit or Hospitalization","Inclusion Criteria:\n\n* Patients aged 40 years or older at the time of arrival to the emergency department.\n* Patients with a clinical diagnosis of COPD who present to the emergency department for a moderate or severe COPD exacerbation.\n* A moderate exacerbation is defined as an acute exacerbation requiring either systemic corticosteroids (such as intramuscular, intravenous or oral) and\u002For antibiotics.\n* A severe exacerbation is defined as an acute exacerbation requiring hospitalization, or observation for \\>24 hours in emergency department\u002Furgent care facility or resulting in death.\n* Patients on dual (LABA\u002FLAMA, LABA\u002FICS, LAMA\u002FICS) or triple (LABA\u002FLAMA\u002FICS) long-acting bronchodilator inhalers.\n\nExclusion Criteria:\n\n* Patients on bronchodilator inhaler monotherapy.\n* Patients leaving against medical advice or expiring during hospitalization.\n* Patients with tracheostomy.\n* Patients with advanced cancer.\n* Patients who have received a lung transplant.\n* Discharge to hospice care.\n* Transfer to another hospital.","ALL","40 Years",{"count":107,"type":108},485,"ESTIMATED","OBSERVATIONAL","The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.",[112],"COPD (Chronic Obstructive Pulmonary Disease)",[114,115,116,117],"COPD","Chronic obstructive pulmonary disease","Exacerbation","VizCOPD","2026-06-02",{"date":120,"type":121},"2026-06-03","ACTUAL",{"date":123,"type":121},"2026-02-27",{"date":125,"type":108},"2027-12",{"name":5,"class":6},4]